PUBLISHER: The Insight Partners | PRODUCT CODE: 1819682
PUBLISHER: The Insight Partners | PRODUCT CODE: 1819682
The North America microplate reader market was valued at approximately US$ 274.79 million in 2023 and is projected to grow to around US$ 423.84 million by 2031, reflecting a compound annual growth rate (CAGR) of 5.6% during the forecast period from 2023 to 2031.
Growth Drivers in the Pharmaceutical Sector
The surge in research and development (R&D) investments within the pharmaceutical industry is a significant factor propelling the North America microplate reader market. Globally, there is an increasing emphasis on drug discovery, with the US biopharmaceutical sector leading the way in the development of innovative therapeutics. The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the foremost biopharmaceutical research companies in the United States, and in 2023, its member companies reported R&D expenditures of approximately US$ 96 billion worldwide. This substantial investment underscores the commitment of pharmaceutical companies to advance drug discovery, gene sequencing, and the development of targeted proteins to address the growing healthcare demands.
The rise of personalized medicine is also contributing to the heightened demand for genetic studies. Precision medicine leverages an individual's genomic data to provide tailored treatments for specific conditions. The increasing incidence of chronic diseases has led to a greater need for biologics, orphan disease drugs, and personalized therapies. In February 2020, the National Human Genome Research Institute (NHGRI) announced a new precision medicine and genomics initiative aimed at enhancing the tools available for diagnosing and treating diseases. The advancements in genomics and proteomics are pivotal trends that are driving the growth of the microplate reader market. Consequently, the increased funding for drug discovery and development activities in the biotechnology and pharmaceutical sectors is significantly boosting the demand for microplate readers. Major companies like Pfizer and Novartis are heavily investing in R&D for new drugs, relying on the high-throughput screening capabilities of modern microplate readers to expedite their research processes.
Overview of the North America Microplate Reader Market
The North America microplate reader market is segmented into three primary regions: the United States, Canada, and Mexico. The growth of this market in North America is characterized by a rising demand for advanced and rapid processing technologies among biopharmaceutical and biotechnology firms, the presence of key market players, and extensive R&D activities conducted by various academic and research institutions.
In North America, the United States represents the largest market for microplate readers. The expansion of the US microplate reader market can be attributed to a significant increase in life science research activities, including genomic and proteomic studies, drug discovery, and clinical diagnostics. For instance, in January 2020, Illumina, Inc. announced a strategic partnership with Roche aimed at accelerating genomic research and enhancing access to genomic technologies. The company is also focused on introducing new products and software, which is expected to further stimulate genomic research. This growth in genomic research is anticipated to positively influence the adoption of microplate readers in the US. Additionally, the increasing number of product launches driven by the demand for advanced processing technologies is expected to create lucrative growth opportunities for the US microplate reader market throughout the forecast period. Notably, in November 2020, Enzo Biochem, a US-based diagnostic company, launched a compact and portable microplate reader designed for clinical diagnostics.
Market Segmentation Analysis
The North America microplate reader market is categorized based on type, application, end user, and country.
Key Players in the Market
Prominent companies operating in the North America microplate reader market include Hercuvan Lab Systems, Molecular Devices LLC, Thermo Fisher Scientific Inc., BMG LABTECH, Promega Corp, Revvity Inc., Bio-Rad Laboratories Inc., Tecan Trading AG, Lonza Group AG, and Agilent Technologies Inc. These companies are key players in the development and distribution of microplate readers, contributing to the market's growth and innovation.